Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Operational Update next post S&P 500 Bullish Patterns: Are Higher Highs Ahead? You may also like Victoria Gold-Silver Exploration Update June 5, 2025 Appeals Court Grants Trump Temporary Reprieve on Tariffs,... May 31, 2025 Variation to Noteholder Agreements May 22, 2025 Finlay Minerals Announces Closing of Non-Brokered Private Placement... June 10, 2025 China Eases Rare Earths Grip, Grants US, EU... June 10, 2025 WCN Raises A$14.4M at an Average 29% Premium... May 19, 2025 CDX May Investor Presentation May 30, 2025 Coelacanth Announces Q1 2025 Financial and Operating Results May 29, 2025 Feedback of U.S. Department of Defense Award Funding May 19, 2025 Crypto Market Recap: Stablecoin Market Makes Headway, SharpLink... June 14, 2025